desipramine has been researched along with u 0126 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ben-Shachar, D; Klein, E; Lucki, A; Yaniv, SP | 1 |
1 other study(ies) available for desipramine and u 0126
Article | Year |
---|---|
Dexamethasone enhances the norepinephrine-induced ERK/MAPK intracellular pathway possibly via dysregulation of the alpha2-adrenergic receptor: implications for antidepressant drug mechanism of action.
Topics: Antidepressive Agents; Butadienes; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Desipramine; Dexamethasone; Down-Regulation; Drug Synergism; Enzyme Activation; Flavonoids; Glucocorticoids; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neuroblastoma; Nitriles; Norepinephrine; Proto-Oncogene Proteins c-fos; Receptors, Adrenergic, alpha-2; Transcription Factor AP-1 | 2010 |